Abstract
To determine the prognostic value of baseline red blood cell distribution width (RDW) in diffuse large B cell lymphoma (DLBCL) patients. Data from 81 DLBCL patients diagnosed from 2006 to 2013 at the University Hospital Center Osijek, Osijek, Croatia, were reviewed. We evaluated disease outcome, overall survival (OS) and event-free survival (EFS), and demographic, clinical and laboratory factors affecting outcome. Univariate analysis and Cox regression analysis were used. Median age of patients was 64 years, 29 were men (35.8%). Higher RDW levels (%) were found in patients with advanced Ann Arbor clinical stage (14.94±1.82 vs 13.55±1.54, P=0.001) and in those with poor response to therapy (14.94±1.82 vs 13.55±1.54, P=0.001). Patients with RDW>15% (cut-off was calculated by receiver operating characteristics) had significantly worse OS (median [range], 33 months [20-46] vs 74 months [65-82], P<0.001) and EFS (27 months [15-40] vs 68 months [59-77], P<0.001). Cox regression analysis showed that RDW>15% was an independent prognostic factor for OS (HR 3.654, 95% CI 1.128-11.836) and EFS (HR 2.611, 95% CI 1.012-6-739). High baseline RDW is an independent prognostic marker of poor outcome in patients with DLBCL. RDW could be an easil...Continue Reading
Citations
Jan 19, 2016·The Science of the Total Environment·E ConroyM Kelly-Quinn
Sep 23, 2016·PloS One·Yan FuQuan Zhang
Apr 14, 2019·Cancer Medicine·Yi MiaoJian-Yong Li
Apr 29, 2016·Medicine·Du-Ping HuangYou-Qun Xiang
Mar 7, 2020·Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals·Qing-Yong YangYan-Song Guo
Dec 8, 2016·Oncotarget·Linhui HuShudao Xiong
Apr 8, 2017·Oncotarget·Shujuan ZhouSongfu Jiang
Dec 2, 2017·Oncotarget·Huaichao LuoSisi Yu
Nov 2, 2017·Oncotarget·Jongheon JungHyeon-Seok Eom
Sep 7, 2017·International Journal of Laboratory Hematology·K NishimuraT Eto
Feb 2, 2019·Molecular Biology Reports·Noha Mohamed Said
Nov 13, 2019·BMC Cancer·Manman LiShudao Xiong
Jun 5, 2020·Journal of Clinical Immunology·Jiayu HuangHongxia Qiu
Aug 23, 2017·Cancer Biomarkers : Section a of Disease Markers·Jing WangHongfeng Guo
Jun 27, 2019·International Journal of Hematology·Takao YogoKenshi Suzuki
Jul 25, 2020·International Urology and Nephrology·Reena PatelMehran Afshar
May 2, 2018·Cancer Cell International·Lisha AiYu Hu
Jan 28, 2021·Analytical Chemistry·Tienan GaoLanqun Mao
Nov 8, 2020·Cancers·Ines HerraezAntonio Gutierrez
Mar 3, 2021·BMC Surgery·Xingchen LiJianqiang Cai
Nov 20, 2020·Leukemia Research·Kosuke ObamaHirosaka Inoue
Nov 18, 2021·Biomarkers in Medicine·Oloche OwoichoOsbourne Quaye